Hyper-IgM Immunodeficiency Syndrome - 27 Studies Found
Recruiting |
: Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies :
: |
Completed |
: Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects : Primary Immune Deficiency Disease : 2008-03-05 : Biological: Flebogamma 5% DIF Intravenous Immune Globulin (Human) |
Active, not recruiting |
: Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204) :
: Biological: Hematopoietic Stem Cell Transplant NOTE: The - |
Completed |
: A Clinical Study of Intravenous Immunoglobulin : Immunologic Deficiency Syndromes : 2007-05-01 : Drug: Immune Globulin Intravenous (Human) Omr-IgG-am IGIV IGIV infusions of 300-900 mg/kg every 3 or 4 w |
Active, not recruiting |
: Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases :
|